XBiotech Inc

(NASDAQ:XBIT)

Latest On XBiotech Inc (XBIT):

Date/Time Type Description Signal Details
2023-05-17 10:00 ESTNewsXBiotech adds 15% on $80M buyback offerN/A
2022-02-03 03:24 ESTNewsXBiotech in antibody manufacturing deal with J&J unit JanssenN/A
2021-12-29 11:09 ESTNewsFDA updates EUA for COVID convalescent plasma limiting use to certain patientsN/A
2021-07-22 09:15 ESTNewsEnrollment underway in XBiotech's XB2001 study in pancreatic cancerN/A
2021-07-22 09:08 ESTNewsXBiotech received $75M from antibody sale of bermekimabN/A
2021-07-22 09:07 ESTNewsXBIT, IMMR, ODT and INSG among after-hours moversN/A
2021-07-22 09:07 ESTNewsXbiotech declares $2.50 special dividendN/A
2021-07-15 05:57 ESTDividendA dividend of $2.5 has been announced on Jul 6, 2021. It will be paid Jul 23, 2021 with an ex-dividend date of Jul 15, 2021.Neutral
2021-04-19 19:44 ESTNewsFDA gives go-ahead for XBiotech’s XB2001 combo therapy in pancreatic cancerN/A
2021-03-30 15:14 ESTNewsXBiotech: True Human Antibody Developer Needs More Candidates In The ClinicN/A
2021-03-18 06:08 ESTFinancialsCompany financials have been released.Neutral
2021-03-02 21:48 ESTNewsNIH halts a convalescent plasma trial in patients with mild COVID-19N/A
2021-01-21 16:33 ESTNewsXBiotech says its antibody therapy is effective against new COVID-19 strainN/A
2020-11-26 22:08 ESTFinancialsCompany financials have been released.Neutral
2020-11-20 06:41 ESTNewsXBiotech's influenza-COVID-19 therapeutic cocktail shows effective anti-virus activityN/A
2020-11-20 06:39 ESTNewsXBiotech: New Q1 2021 Clinical Announcement, 9M 2020 Confirmed Short-Term Janssen Revenues, 2022 Is Uncertain, +28% UpsideN/A
2020-11-11 05:27 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 23:15 ESTNewsCOVID-19 treatment developers under pressure on positive COVID-19 vaccine dataN/A
2020-11-08 01:21 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:37 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 14:37 ESTFinancialsCompany financials have been released.Neutral
2020-09-22 12:52 ESTNewsXBiotech launches new Influenza-COVID-19 antibody treatmentN/A
2020-09-17 06:42 ESTFinancialsCompany financials have been released.Neutral
2020-09-16 17:09 ESTInsider TradeSUSHMA SHIVASWAMY has directly disposed of 20,668 shares and currently holds 0 shares.Sell
2020-09-16 17:09 ESTInsider TradeSUSHMA SHIVASWAMY has directly acquired 20,668 shares and currently holds 20,668 shares.Buy
2020-09-16 17:09 ESTInsider TradeSUSHMA SHIVASWAMY has directly disposed of 19,332 shares and currently holds 0 shares.Sell
2020-09-16 17:08 ESTInsider TradeSUSHMA SHIVASWAMY has directly acquired 19,332 shares and currently holds 19,332 shares.Buy
2020-09-02 11:51 ESTInsider TradeQUEENA HAN has directly acquired 27,692 shares and currently holds 57,692 shares.Buy
2020-09-02 11:51 ESTInsider TradeQUEENA HAN has directly acquired 30,000 shares and currently holds 30,000 shares.Buy
2020-09-01 23:47 ESTNewsNIH begs to differ on FDA's EUA for convalescent plasma for COVID-19N/A
2020-08-29 13:50 ESTNewsDoes convalescent plasma help COVID-19 patients? Studies will answerN/A
2020-08-26 15:30 ESTInsider TradeQUEENA HAN has directly acquired 12,500 shares and currently holds 12,500 shares.Buy
2020-08-26 15:30 ESTInsider TradeQUEENA HAN has directly acquired 3,333 shares and currently holds 3,333 shares.Buy
2020-08-26 15:30 ESTInsider TradeQUEENA HAN has directly acquired 12,308 shares and currently holds 12,308 shares.Buy
2020-08-26 15:30 ESTInsider TradeQUEENA HAN has directly acquired 5,000 shares and currently holds 5,000 shares.Buy
2020-08-26 15:30 ESTInsider TradeQUEENA HAN has directly disposed of 18,700 shares and currently holds 0 shares.Sell
2020-08-26 15:30 ESTInsider TradeQUEENA HAN has directly acquired 18,700 shares and currently holds 18,700 shares.Buy
2020-08-24 17:55 ESTNewsFDA allows emergency use of convalescent plasma to treat COVID-19N/A
2020-08-24 17:55 ESTNewsConvalescent plasma players rally on FDA emergency use nodN/A
2020-08-24 17:54 ESTNewsXBiotech +11% on FDA's approval on convalescent plasma for Covid treatmentN/A
2020-08-21 15:32 ESTInsider TradeQUEENA HAN has directly disposed of 1,300 shares and currently holds 0 shares.Sell
2020-08-21 15:32 ESTInsider TradeQUEENA HAN has directly acquired 1,300 shares and currently holds 1,300 shares.Buy
2020-08-20 02:54 ESTNewsConvalescent plasma players under pressure on FDA hold on emergency use nodN/A
2020-08-17 18:40 ESTNewsXBiotech up 16% on discovery of COVID-19 candidatesN/A
2020-08-14 10:37 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 05:43 ESTNewsConvalescent plasma players rally on positive results from COVID-19 studyN/A
2020-08-12 06:17 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 09:58 ESTFinancialsCompany financials have been released.Neutral
2020-08-04 00:48 ESTNewsXBiotech: Well-Funded, Working On The Next Bermekimab, And UndervaluedN/A
2020-08-01 08:53 ESTNewsXBiotech: Well Funded, Working On The Next Bermekimab, And UndervaluedN/A

About XBiotech Inc (XBIT):

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of antibody therapies for treating oncology, inflammatory conditions, and infectious diseases. Its product candidates include 514G3, an anti-infective antibody that is in Phase II clinical trial for the treatment of Staphylococcus Aureus infections; and other anti-infectious disease antibodies, which are in pre-clinical development to treat Clostridium Difficile, influenza, Ebola, and Herpes Varicella Zoster (Chickenpox). XBiotech Inc. has a collaboration with BioBridge Global for the development of potential COVID 19 treatment based on natural antibodies from recovered patients. The company was founded in 2005 and is headquartered in Austin, Texas.

XBIT Quotes by TradingView

See Advanced Chart

General

  • Name XBiotech Inc
  • Symbol XBIT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 91
  • Fiscal Year EndDecember
  • IPO Date2015-04-15
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.xbiotech.com
View More

Valuation

  • Trailing PE 1.2
  • Price/Sales (Trailing 12 Mt.) 19.95
  • Price/Book (Most Recent Quarter) 1.59
  • Enterprise Value Revenue 8.02
  • Enterprise Value EBITDA 10.06
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin -26%
  • Operating Margin -42%
  • Return on Assets -2%
  • Return on Equity -2%
  • Revenue 44 million
  • Earnings Per Share $16.45
  • Revenue Per Share $1.43
  • Gross Profit 9.45 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 583.28 million
  • EBITDA -20601000
  • PE Ratio -8.43
  • Analyst Target Price $18
  • Book Value Per Share $11.84
View More

Share Statistics

  • Shares Outstanding 29.46 million
  • Shares Float 18.03 million
  • % Held by Insiders 3940%
  • % Held by Institutions 14.4%
  • Shares Short 1.5 million
  • Shares Short Prior Month 1.55 million
  • Short Ratio 12.36
  • Short % of Float 10%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 1.45
  • 52 Week High $21.48
  • 52 Week Low $9.12
  • 50 Day Moving Average 19.46
  • 200 Day Moving Average 18.66
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

XBiotech Inc (XBIT) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount
2021-07-152021-07-232021-07-162021-07-06$2.5

XBiotech Inc (XBIT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-15$N/A-$0.06
2020-09-302020-11-09$N/A-$0.09
2020-06-302020-08-10$N/A-$0.24$0.04-693%
2020-03-312020-05-11$12.68 million$-0.00$0.06-100.67%
2019-12-312020-03-16$N/A$14.82-$0.159980%
2019-09-302019-11-12$N/A-$0.15-$0.150%
2019-06-302019-08-09$N/A-$0.16-$0.15-6.67%
2019-03-312019-05-09$N/A-$0.16
2018-12-312019-03-14$N/A-$0.17-$0.4763.79%
2018-09-302018-10-31$N/A-$0.14-$0.4770%
2018-06-302018-08-09$N/A-$0.16-$0.4764.91%
2018-03-312018-05-08$N/A-$0.11-$0.4775.57%
2017-12-312018-03-16$N/A-$0.20-$0.4756.49%
2017-09-302017-11-09$N/A-$0.18-$0.4762.72%
2017-06-302017-08-08$N/A-$0.26-$0.4744.98%
2017-03-312017-05-10$N/A-$0.32-$0.4731.91%
2016-12-312017-03-16$N/A-$0.51-$0.42-21.43%
2016-09-302016-11-14$N/A-$0.38-$0.4617.39%
2016-06-302016-08-12$N/A-$0.42-$0.35-20%
2016-03-312016-05-13$N/A-$0.32-$0.3917.95%
2015-12-312016-03-30$N/A-$0.38-$0.35-8.57%
2015-09-302015-11-13$N/A-$0.34
2015-06-302015-08-14$N/A-$0.22
2015-03-312015-04-17$N/A-$0.29

XBiotech Inc (XBIT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

XBiotech Inc (XBIT) Chart:

XBiotech Inc (XBIT) News:

Below you will find a list of latest news for XBiotech Inc (XBIT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

XBiotech Inc (XBIT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-01-172.50CALL0 0315.5TRUE00
2025-01-1752.05CALL0 2207.28TRUE00
2025-01-177.51.5CALL0 2579.55FALSE00
2025-01-17100CALL0 00FALSE00
2025-01-1712.50CALL0 0102.12FALSE00
2025-01-17150CALL0 00FALSE00
2025-01-1717.50CALL0 00FALSE00
2025-01-172.50PUT0 00FALSE00
2025-01-1750PUT0 00FALSE00
2025-01-177.52.85PUT0 5188.67TRUE00
2025-01-17102.7PUT0 070.99TRUE00
2025-01-1712.50PUT0 0141.58TRUE00
2025-01-17150PUT0 0154.3TRUE00
2025-01-1717.50PUT0 0178.18TRUE00
2025-04-172.50CALL0 0261TRUE00
2025-04-1750CALL0 0159.01TRUE00
2025-04-177.50CALL0 00FALSE00
2025-04-17100CALL0 00FALSE00
2025-04-1712.50CALL0 00FALSE00
2025-04-172.50PUT0 00FALSE00
2025-04-1750PUT0 00FALSE00
2025-04-177.50PUT0 0148.16TRUE00
2025-04-17100PUT0 093.61TRUE00
2025-04-1712.50PUT0 098.76TRUE00

Latest XBIT Trades:

Date Shares Price
Jun 13, 2022 7:57 PM EST29$5.59
Jun 13, 2022 7:57 PM EST10$5.6
Jun 13, 2022 7:58 PM EST20$5.61
Jun 13, 2022 7:58 PM EST80$5.61
Jun 13, 2022 7:59 PM EST74$5.61

XBiotech Inc (XBIT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184320004608/0001171843-20-004608-index.htm
2018-07-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1626878/000000000018022716/0000000000-18-022716-index.htm
2018-08-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1626878/000000000018024294/0000000000-18-024294-index.htm
2018-10-01UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1626878/000000000018030816/0000000000-18-030816-index.htm
2020-02-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000110465920016125/0001104659-20-016125-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1626878/000110465920019844/0001104659-20-019844-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000110465920021546/0001104659-20-021546-index.htm
2020-02-194/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000110465920022929/0001104659-20-022929-index.htm
2020-03-054/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000110465920029536/0001104659-20-029536-index.htm
2018-03-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184318002197/0001171843-18-002197-index.htm
2018-03-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184318002228/0001171843-18-002228-index.htm
2018-04-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184318002645/0001171843-18-002645-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1626878/000117184318003188/0001171843-18-003188-index.htm
2018-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1626878/000117184318003195/0001171843-18-003195-index.htm
2018-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1626878/000117184318003654/0001171843-18-003654-index.htm
2018-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184318004776/0001171843-18-004776-index.htm
2018-07-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1626878/000117184318005555/0001171843-18-005555-index.htm
2018-07-3110-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1626878/000117184318005556/0001171843-18-005556-index.htm
2018-07-3110-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1626878/000117184318005559/0001171843-18-005559-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1626878/000117184318005920/0001171843-18-005920-index.htm
2018-09-0510-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1626878/000117184318006385/0001171843-18-006385-index.htm
2018-09-0510-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1626878/000117184318006389/0001171843-18-006389-index.htm
2018-09-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1626878/000117184318006390/0001171843-18-006390-index.htm
2018-10-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184318007152/0001171843-18-007152-index.htm
2018-10-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1626878/000117184318007413/0001171843-18-007413-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1626878/000117184319000937/0001171843-19-000937-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1626878/000117184319000938/0001171843-19-000938-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1626878/000117184319001708/0001171843-19-001708-index.htm
2019-03-1510-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1626878/000117184319001758/0001171843-19-001758-index.htm
2019-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184319002224/0001171843-19-002224-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1626878/000117184319002757/0001171843-19-002757-index.htm
2019-05-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1626878/000117184319002820/0001171843-19-002820-index.htm
2019-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184319002822/0001171843-19-002822-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1626878/000117184319003199/0001171843-19-003199-index.htm
2019-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184319003710/0001171843-19-003710-index.htm
2019-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184319003712/0001171843-19-003712-index.htm
2019-05-31424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1626878/000117184319003722/0001171843-19-003722-index.htm
2019-05-31S-3MEFRegistration adding securities to prior Form S-3 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1626878/000117184319003727/0001171843-19-003727-index.htm
2019-06-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1626878/000117184319003791/0001171843-19-003791-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184319003792/0001171843-19-003792-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184319004081/0001171843-19-004081-index.htm
2019-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184319004604/0001171843-19-004604-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1626878/000117184319005378/0001171843-19-005378-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1626878/000117184319007437/0001171843-19-007437-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184319008024/0001171843-19-008024-index.htm
2019-12-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184319008353/0001171843-19-008353-index.htm
2020-02-05SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1626878/000117184320000727/0001171843-20-000727-index.htm
2020-02-13SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1626878/000117184320000946/0001171843-20-000946-index.htm
2020-02-13SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1626878/000117184320000960/0001171843-20-000960-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1626878/000117184320000995/0001171843-20-000995-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1626878/000117184320000996/0001171843-20-000996-index.htm
2020-02-19SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1626878/000117184320001053/0001171843-20-001053-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1626878/000117184320001761/0001171843-20-001761-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1626878/000117184320002999/0001171843-20-002999-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1626878/000117184320003009/0001171843-20-003009-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1626878/000117184320003601/0001171843-20-003601-index.htm
2020-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1626878/000117184320004608/0001171843-20-004608-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1626878/000117184320005794/0001171843-20-005794-index.htm
2020-10-02S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1626878/000117184320006830/0001171843-20-006830-index.htm
2019-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1626878/000119312519031003/0001193125-19-031003-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1626878/000119312519040348/0001193125-19-040348-index.htm
2019-06-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1626878/000119312519171209/0001193125-19-171209-index.htm
2020-01-21SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1626878/000119312520011020/0001193125-20-011020-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1626878/000119312520035356/0001193125-20-035356-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1626878/000119312520035368/0001193125-20-035368-index.htm
2018-03-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118021230/0001209191-18-021230-index.htm
2018-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118021232/0001209191-18-021232-index.htm
2018-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118021609/0001209191-18-021609-index.htm
2018-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118029438/0001209191-18-029438-index.htm
2018-06-123/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118037200/0001209191-18-037200-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118038901/0001209191-18-038901-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118038902/0001209191-18-038902-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118038903/0001209191-18-038903-index.htm
2018-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118038904/0001209191-18-038904-index.htm
2018-06-214/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118038967/0001209191-18-038967-index.htm
2018-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118044669/0001209191-18-044669-index.htm
2018-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118045282/0001209191-18-045282-index.htm
2018-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118045840/0001209191-18-045840-index.htm
2018-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118046477/0001209191-18-046477-index.htm
2018-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118049834/0001209191-18-049834-index.htm
2018-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118050529/0001209191-18-050529-index.htm
2018-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118051357/0001209191-18-051357-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118052662/0001209191-18-052662-index.htm
2018-10-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118054253/0001209191-18-054253-index.htm
2018-10-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118054878/0001209191-18-054878-index.htm
2018-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118058294/0001209191-18-058294-index.htm
2018-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118063616/0001209191-18-063616-index.htm
2018-12-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919118064318/0001209191-18-064318-index.htm
2019-02-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119010052/0001209191-19-010052-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119010053/0001209191-19-010053-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119015316/0001209191-19-015316-index.htm
2019-03-044/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119015475/0001209191-19-015475-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119015553/0001209191-19-015553-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119015691/0001209191-19-015691-index.htm
2019-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119015702/0001209191-19-015702-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119016489/0001209191-19-016489-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119034978/0001209191-19-034978-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119039527/0001209191-19-039527-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119039641/0001209191-19-039641-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119039647/0001209191-19-039647-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119039652/0001209191-19-039652-index.htm
2019-09-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119048851/0001209191-19-048851-index.htm
2019-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119048852/0001209191-19-048852-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119055793/0001209191-19-055793-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119055794/0001209191-19-055794-index.htm
2019-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119059014/0001209191-19-059014-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919119060015/0001209191-19-060015-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120002718/0001209191-20-002718-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120009263/0001209191-20-009263-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120009272/0001209191-20-009272-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120009282/0001209191-20-009282-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120009318/0001209191-20-009318-index.htm
2020-02-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120009321/0001209191-20-009321-index.htm
2020-03-194/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120020219/0001209191-20-020219-index.htm
2020-03-194/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120020220/0001209191-20-020220-index.htm
2020-03-194/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120020221/0001209191-20-020221-index.htm
2020-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120021067/0001209191-20-021067-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120047889/0001209191-20-047889-index.htm
2020-08-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120048337/0001209191-20-048337-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120048897/0001209191-20-048897-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120048898/0001209191-20-048898-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120048900/0001209191-20-048900-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120048901/0001209191-20-048901-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120049028/0001209191-20-049028-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120050693/0001209191-20-050693-index.htm
2020-09-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1626878/000120919120051306/0001209191-20-051306-index.htm
2020-01-14SC TO-ITender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1626878/000138713120000238/0001387131-20-000238-index.htm

XBiotech Inc (XBIT) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of XBiotech Inc (XBIT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 3940%
Institutional Ownership: 1440%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-03-21QUEENA HANVP Finance & HRSell9,599.004.4842,987.200.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118021609/0001209191-18-021609-index.htm
2018-03-22QUEENA HANVP Finance & HRSell62,200.004.76296,159.080.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118021609/0001209191-18-021609-index.htm
2018-03-23QUEENA HANVP Finance & HRSell8,201.004.7538,954.750.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118021609/0001209191-18-021609-index.htm
2020-08-17QUEENA HANVP Finance & HRSell1,300.0019.3025,090.000.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120047889/0001209191-20-047889-index.htm
2020-08-24QUEENA HANVP Finance & HRSell18,700.0019.65367,535.410.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120048337/0001209191-20-048337-index.htm
2019-02-07SUSHMA SHIVASWAMYChief Scientific OfficerSell4,500.0010.0045,000.000.00https://www.sec.gov/Archives/edgar/data/1626878/000120919119015553/0001209191-19-015553-index.htm
2020-09-10SUSHMA SHIVASWAMYChief Scientific OfficerSell19,332.0020.01386,833.320.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120050693/0001209191-20-050693-index.htm
2020-09-15SUSHMA SHIVASWAMYChief Scientific OfficerSell20,668.0020.00413,360.000.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120050693/0001209191-20-050693-index.htm
2018-08-10W THORPE MCKENZIEDirectorSell3,171.003.9812,623.120.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118046477/0001209191-18-046477-index.htm
2018-08-08W THORPE MCKENZIEDirectorSell4,000.004.0116,024.00121,309.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118045840/0001209191-18-045840-index.htm
2020-08-24QUEENA HANVP Finance & HRBuy12,308.004.1651,201.2812,308.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120048337/0001209191-20-048337-index.htm
2020-08-24QUEENA HANVP Finance & HRBuy12,500.005.2665,750.0012,500.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120048337/0001209191-20-048337-index.htm
2018-08-07W THORPE MCKENZIEDirectorSell8,452.003.9433,332.15125,309.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118045840/0001209191-18-045840-index.htm
2020-08-17QUEENA HANVP Finance & HRBuy1,300.007.509,750.001,300.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120047889/0001209191-20-047889-index.htm
2018-08-06W THORPE MCKENZIEDirectorSell3,340.003.9913,327.60133,761.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118045840/0001209191-18-045840-index.htm
2020-08-24QUEENA HANVP Finance & HRBuy18,700.007.50140,250.0018,700.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120048337/0001209191-20-048337-index.htm
2020-09-10SUSHMA SHIVASWAMYChief Scientific OfficerBuy19,332.007.50144,990.0019,332.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120050693/0001209191-20-050693-index.htm
2020-02-12Jan-Paul WaldinDirectorSell95,612.0030.002,868,360.00204,388.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120009282/0001209191-20-009282-index.htm
2020-09-15SUSHMA SHIVASWAMYChief Scientific OfficerBuy20,668.007.50155,010.0020,668.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120050693/0001209191-20-050693-index.htm
2018-11-09W THORPE MCKENZIEDirectorBuy2,200.003.748,217.002,200.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118058294/0001209191-18-058294-index.htm
2018-08-03W THORPE MCKENZIEDirectorSell23,900.003.9694,689.4125,601.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118045282/0001209191-18-045282-index.htm
2018-12-24W THORPE MCKENZIEDirectorBuy24,838.005.88146,097.1227,738.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118064318/0001209191-18-064318-index.htm
2018-11-12W THORPE MCKENZIEDirectorBuy700.003.752,625.002,900.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118058294/0001209191-18-058294-index.htm
2020-02-12W THORPE MCKENZIEDirectorSell1,401,856.0030.0042,055,680.002,996,744.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120009263/0001209191-20-009263-index.htm
2020-09-01QUEENA HANVP Finance & HRBuy30,000.004.24127,200.0030,000.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120049028/0001209191-20-049028-index.htm
2018-12-26W THORPE MCKENZIEDirectorBuy3,600.005.0017,996.0431,338.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118064318/0001209191-18-064318-index.htm
2018-08-09W THORPE MCKENZIEDirectorSell6,638.004.0026,523.463,171.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118046477/0001209191-18-046477-index.htm
2020-02-12W THORPE MCKENZIEDirectorSell15,214.0030.00456,420.0032,524.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120009263/0001209191-20-009263-index.htm
2018-12-27W THORPE MCKENZIEDirectorBuy1,364.004.926,705.8332,702.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118064318/0001209191-18-064318-index.htm
2020-08-24QUEENA HANVP Finance & HRBuy3,333.004.1413,798.623,333.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120048337/0001209191-20-048337-index.htm
2020-02-19STREET FINANCIAL S.A. BAY10% Share HolderSell1,662,616.006.3810,607,490.083,337,384.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120021067/0001209191-20-021067-index.htm
2018-10-04W THORPE MCKENZIEDirectorSell385,000.003.001,155,000.003,398,600.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118054253/0001209191-18-054253-index.htm
2019-11-29W THORPE MCKENZIEDirectorBuy185,000.003.75693,750.003,583,600.00https://www.sec.gov/Archives/edgar/data/1626878/000120919119059014/0001209191-19-059014-index.htm
2018-12-21FONDATION RENNES10% Share HolderBuy4,200.006.2426,208.003,590,182.00https://www.sec.gov/Archives/edgar/data/1626878/000120919119010053/0001209191-19-010053-index.htm
2018-12-27FONDATION RENNES10% Share HolderBuy2,200.004.9810,956.003,592,382.00https://www.sec.gov/Archives/edgar/data/1626878/000120919119010053/0001209191-19-010053-index.htm
2019-01-02FONDATION RENNES10% Share HolderBuy900.005.154,635.003,593,282.00https://www.sec.gov/Archives/edgar/data/1626878/000120919119010053/0001209191-19-010053-index.htm
2019-02-06FONDATION RENNES10% Share HolderBuy35,000.008.93312,550.003,628,282.00https://www.sec.gov/Archives/edgar/data/1626878/000120919119010053/0001209191-19-010053-index.htm
2019-02-06FONDATION RENNES10% Share HolderBuy30,000.009.49284,700.003,658,282.00https://www.sec.gov/Archives/edgar/data/1626878/000120919119010053/0001209191-19-010053-index.htm
2019-02-07FONDATION RENNES10% Share HolderBuy40,000.0010.00400,000.003,698,282.00https://www.sec.gov/Archives/edgar/data/1626878/000120919119010053/0001209191-19-010053-index.htm
2020-01-06W THORPE MCKENZIEDirectorBuy123,000.003.75461,250.003,706,600.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120002718/0001209191-20-002718-index.htm
2018-09-26W THORPE MCKENZIEDirectorSell17,634.003.0553,797.813,783,600.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118052662/0001209191-18-052662-index.htm
2018-09-13W THORPE MCKENZIEDirectorSell7,909.003.1024,548.753,801,234.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118051357/0001209191-18-051357-index.htm
2018-09-12W THORPE MCKENZIEDirectorSell41,675.003.06127,546.343,809,143.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118051357/0001209191-18-051357-index.htm
2018-09-10W THORPE MCKENZIEDirectorSell23,369.003.2275,334.653,850,818.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118050529/0001209191-18-050529-index.htm
2019-02-27FONDATION RENNES10% Share HolderBuy5,273.008.1342,869.493,853,555.00https://www.sec.gov/Archives/edgar/data/1626878/000120919119015316/0001209191-19-015316-index.htm
2019-02-28FONDATION RENNES10% Share HolderBuy5,302.008.1943,423.383,858,857.00https://www.sec.gov/Archives/edgar/data/1626878/000120919119015316/0001209191-19-015316-index.htm
2018-09-07W THORPE MCKENZIEDirectorSell6,234.003.6522,762.833,874,187.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118050529/0001209191-18-050529-index.htm
2019-09-06W THORPE MCKENZIEDirectorSell7,159.003.6926,396.663,880,421.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118049834/0001209191-18-049834-index.htm
2018-09-05W THORPE MCKENZIEDirectorSell7,220.003.9428,480.733,887,580.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118049834/0001209191-18-049834-index.htm
2019-03-01FONDATION RENNES10% Share HolderBuy34,999.008.13284,541.873,893,856.00https://www.sec.gov/Archives/edgar/data/1626878/000120919119015316/0001209191-19-015316-index.htm
2018-09-04W THORPE MCKENZIEDirectorSell3,800.003.9915,179.103,894,800.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118049834/0001209191-18-049834-index.htm
2019-03-04FONDATION RENNES10% Share HolderBuy16,426.007.91129,929.663,910,282.00https://www.sec.gov/Archives/edgar/data/1626878/000120919119016489/0001209191-19-016489-index.htm
2020-02-12THOMAS GUT10% Share HolderSell1,868,870.0030.0056,066,100.003,995,170.00https://www.sec.gov/Archives/edgar/data/1626878/000110465920021546/0001104659-20-021546-index.htm
2020-02-12JOHN SIMARDChief Executive OfficerSell2,016,466.0030.0060,493,980.004,310,594.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120009272/0001209191-20-009272-index.htm
2019-02-07SUSHMA SHIVASWAMYChief Scientific OfficerBuy4,500.002.5011,250.004,500.00https://www.sec.gov/Archives/edgar/data/1626878/000120919119015553/0001209191-19-015553-index.htm
2018-08-02W THORPE MCKENZIEDirectorSell30,461.003.92119,528.9649,501.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118045282/0001209191-18-045282-index.htm
2020-08-24QUEENA HANVP Finance & HRBuy5,000.0015.0075,000.005,000.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120048337/0001209191-20-048337-index.htm
2019-06-04FONDATION RENNES10% Share HolderBuy1,200,000.008.259,900,000.005,110,282.00https://www.sec.gov/Archives/edgar/data/1626878/000120919119034978/0001209191-19-034978-index.htm
2020-09-01QUEENA HANVP Finance & HRBuy27,692.004.16115,198.7257,692.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120049028/0001209191-20-049028-index.htm
2018-03-22QUEENA HANVP Finance & HRBuy62,200.002.50155,500.0062,200.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118021609/0001209191-18-021609-index.htm
2018-12-19JOHN SIMARDChief Executive OfficerBuy50,000.002.50125,000.006,327,060.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118063616/0001209191-18-063616-index.htm
2020-02-12W THORPE MCKENZIEDirectorSell31,870.0030.00956,100.0068,130.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120009263/0001209191-20-009263-index.htm
2020-02-12W THORPE MCKENZIEDirectorSell3,665.0030.00109,950.007,835.00https://www.sec.gov/Archives/edgar/data/1626878/000120919120009263/0001209191-20-009263-index.htm
2018-08-01W THORPE MCKENZIEDirectorSell8,163.004.2434,649.4979,962.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118045282/0001209191-18-045282-index.htm
2018-03-23QUEENA HANVP Finance & HRBuy8,201.002.5020,502.508,201.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118021609/0001209191-18-021609-index.htm
2018-07-31W THORPE MCKENZIEDirectorSell6,531.004.4929,320.2788,125.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118044669/0001209191-18-044669-index.htm
2018-07-30W THORPE MCKENZIEDirectorSell5,344.004.4123,542.4694,656.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118044669/0001209191-18-044669-index.htm
2018-03-21QUEENA HANVP Finance & HRBuy9,599.002.5023,997.509,599.00https://www.sec.gov/Archives/edgar/data/1626878/000120919118021609/0001209191-18-021609-index.htm